Sugaring the pill: The most recent legislative proposal by the European Commission, which tackles inequality in the pharmaceutical industry, has sparked conflict between lawmakers and the industry. Keeping in mind that poorer Eastern European countries receive medicines slower than their Western counterparts, what steps should the EU take to fairly grant access to new drugs to all and avoid shortages of pharmaceuticals?